CDC Investment in Antimicrobial Resistance

The CDC released the latest version of its Antimicrobial Resistance (AR) Investment Map, highlighting the agency’s funding in the U.S. and around the world to combat the global threat of AR in FY 2022. CDC funds AR activities in every U.S. state to detect, respond to, contain, and prevent resistant infections across healthcare, the community, the food supply, and the environment.